US Patent Issued to THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA on Dec. 30 for "Hydroxybenzamide derivatives and methods of use in treating diabetes" (Oklahoma Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,429, issued on Dec. 30, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (Norman, Okla.).

"Hydroxybenzamide derivatives and methods of use in treating diabetes" was invented by Venkateswararao Eeda (Oklahoma City) and Weidong Wang (Edmond, Okla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hydroxybenzamide derivative compounds having Beta-cell protective activity against ER stress, and methods of their use in treating diabetes and other conditions and diseases associated with ER stress. In one non-limiting embodiment, the derivative is 3-hydroxy-N-(4-(trifluoromethyl)benzyl)benzamide."

The patent was filed on April 28, 2023, und...